S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis
Laura Sahyoun(Cornell University), Deborah D. Proctor(Yale University), Jill Gaidos(Yale University), Petr Protiva(Yale University), Badr Al‐Bawardy(King Faisal Specialist Hospital & Research Centre), Chandler McMillan(Yale University), Jonathan Fetene(Yale University)
Cited by 0
Related Papers
Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
|Nature Genetics|2009|393
Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium
|The American Journal of Gastroenterology|2012|190
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
|PLoS Genetics|2012|160
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition
|Gastroenterology|2016|153
The Influence of Depression on Quality of Life in Patients with Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2013|119